What is PGxPredict™: CLOZAPINE ?
The PGxPredict™: CLOZAPINE test is a pharmacogenetic test that will provide information on whether a patient is at Higher or Lower Risk of developing clozapine-induced agranulocytosis compared to patients who have not been tested. The test is intended to be used as an adjunct to existing clinical information to aid in determining the risk of developing clozapine-induced agranulocytosis, and the risk-benefit ratio of clozapine treatment.